Immunovant (IMVT)
(Delayed Data from NSDQ)
$29.23 USD
-0.36 (-1.22%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $29.22 -0.01 (-0.03%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.62 | -0.54% |
Earnings Summary
For their last quarter, Immunovant (IMVT) reported earnings of -$0.60 per share, missing the Zacks Consensus Estimate of -$0.52 per share. This reflects a negative earnings surprise of 15.38%. Look out for IMVT's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.62 per share, reflecting a year-over-year decrease of 37.78%.
Earnings History
Price & Consensus
Zacks News for IMVT
IMVT Stock Up on Upbeat Data From Graves' Disease Study of Batoclimab
IMVT: What are Zacks experts saying now?
Zacks Private Portfolio Services